July 17, 2023 03:37 PM EDTUpdated August 25, 06:24 AM
Deals
R&D

No­vo Nordisk inks re­search deal with RNA start­up with new de­liv­ery ap­proach

Paul Schloesser

Associate Editor

No­vo Nordisk is col­lab­o­rat­ing with RNA up­start Eleven Ther­a­peu­tics in a bid to iden­ti­fy new med­i­cines that can de­liv­er nu­cle­ic acids.

The deal,

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Trump names Johns Hop­kins re­searcher Mar­ty Makary to lead the FDA; al­so names CDC, Sur­geon Gen­er­al picks

FDA ap­proves Bridge­Bio's heart dis­ease drug, set­ting up com­pe­ti­tion with Pfiz­er, Al­ny­lam

Drug or bi­o­log­ic? An Eli Lil­ly law­suit could im­pact weight loss drug com­pounders

Pa­tient dies in Neu­ro­gene's Rett syn­drome study

Lil­ly's board un­der­goes more changes; Mer­ck strat­e­gy chief joins Roger Perl­mut­ter at Eikon

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times